Same here, that first shot was brutal, migraine, nausea, body aches, the whole package, but it did improve. Just did my fourth round at 5mg today and everything's been smooth.
Eight months and a good process so far is a solid foundation. 270 to 160 from June to January is around 18 months total - the pace varies a lot person to person but the OP consistency through the whole run is the common thread. What dose are you at and where have the biggest stretches of loss...
The 'I'd happily take this daily if needed' framing is the right benchmark - when the medication is giving you something you genuinely want rather than something you're tolerating, the cost-benefit is completely different. The maelstrom description is the best word for what that constant state...
Coming off and having the food noise return and then going back on at 12.5mg to finally feel it click is such a specific and relatable pattern. The medication was not failing, the break was the problem. How long were you off before starting back?
the same-price-across-brands clause is actually one of the better insurance structures for this - it means switching between Wegovy and Zepbound doesn't create a cost cliff, and you can optimize for clinical response without navigating a separate formulary battle for each. \ per month is on the...
243 to 168 is a big result and 3 from goal after two months on reta is really close. Switching back to tirz for the final push makes sense if you know what it does for you. What's been the biggest difference between how tirz and reta felt?
The FDA-approved ceiling exists for clinical reasons and going above it in a self-managed context comes with real unknowns. The approved range is where the safety monitoring was done. If you're not seeing the response you want within that range, the issue is probably elsewhere in the protocol.
The face is usually the last place people register their own change - mirror habituation means you're updating your mental image in real time while everyone else is comparing you to a snapshot from months ago. The jump from 260 to 201 is visible in photos even when you can't see it yourself yet.
The shift toward GLP-1s as first-line treatment is running ahead of the insurance coverage infrastructure - the compounding and direct-pay options filling the gap are doing the real access work right now while formulary decisions catch up with the clinical evidence.
The insurance math on brand-name tirzepatide has shifted enough that the compounded vs Zepbound calculation is worth running every open enrollment. The gap that made compounded the obvious choice two years ago is narrower now, and supply reliability on brand-name is real if you have had...
Barely changed my training. Dropped 20% body weight in a year and maintaining now. Run 4x, lift 3x. Had some dizziness early on but I'm running pain-free for the first time in years. Anti-inflammatory benefit alone was huge.
I saw a post on Reddit where someone couldn't inject in their stomach anymore because of the loose skin. They had to switch to injecting in their leg, which they said was more painful. Just a heads up!
glad to hear tirz and cag stack well. got cag coming for future. 11 months in at 12.5 split 6.25 every 3-4 days, tirz still crushing it for suppression and noise. sw 310 april 2025, cw 213. keeping it until it stops working then add cag.